Recombinant Human BCOR Protein，His

BCOR (B-Cell Lymphoma Occurrence Region) is a gene that encodes a protein involved in various cellular processes, including transcriptional regulation, development, and differentiation. The study of BCOR recombined proteins has gained significant attention due to their implications in both normal developmental processes and the pathogenesis of various diseases, particularly in hematological malignancies. BCOR has been identified as a critical player in developmental mechanisms, and mutations or dysregulation of this gene can lead to severe congenital disorders and have been associated with cancers such as B-cell lymphomas. Research into BCOR recombination proteins focuses on elucidating their structure, functionality, and the molecular pathways they influence. Through advanced techniques such as CRISPR-Cas9 gene editing, researchers are able to create specific BCOR variants, allowing for detailed studies on the role of BCOR in cell signaling and gene expression. Additionally, the investigation of BCOR's interactions with other proteins and its role in epigenetic regulation has opened new avenues for understanding its contributions to oncogenesis. This research is essential for developing potential therapeutic strategies aimed at targeting BCOR-related pathways to treat malignancies and other disorders where BCOR mutations play a pivotal role. By building a comprehensive understanding of BCOR's role in both healthy and diseased states, scientists aim to pave the way for innovative treatments and improve patient outcomes in BCOR-related diseases.